September 23, 2025Frontiers in ImmunologyOpen Access

Identification of blood immunological biomarkers of SARS-CoV-2 infection during pandemic in Poland

View Full Paper

Ask AI

Bookmark

Authors

MLMonika LeśniakWojskowy Instytut Medyczny ABAgata Borkowska KKKajetan Klos

Discussion

Member takes

Implication

Observational analysis identified CXCL10 and lymphocyte counts as potential biomarkers in COVID-19 patients, suggesting predictive value for disease severity.

Key Points

Decreased total lymphocyte and T lymphocyte counts were observed in COVID-19 patients, indicating immune response alterations.
CXCL10 was notably elevated in severe COVID-19 cases upon admission, serving as a potential severity predictor.
Cohort included 52 hospitalized adults with SARS-CoV-2 infection, categorized by symptom severity for analysis.
Findings support CXCL10 and lymphocyte metrics as useful in predicting COVID-19 progression and tailoring patient management.

Cite This Study

Leśniak et al. (2025) studied this question.

synapsesocial.com/papers/68d43d83713b0b5dfea7dcc4 https://doi.org/10.3389/fimmu.2025.1613629

View Full Paper

Ask AI

Bookmark

Implication

Observational analysis identified CXCL10 and lymphocyte counts as potential biomarkers in COVID-19 patients, suggesting predictive value for disease severity.

Identification of blood immunological biomarkers of SARS-CoV-2 infection during pandemic in Poland

Discussion

Member takes

Implication

Key Points

Cite This Study

Identification of blood immunological biomarkers of SARS-CoV-2 infection during pandemic in Poland

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider